King TA - Search Results

1

Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer.

Dominici L, Hu J, Zheng Y, Kim HJ, King TA, Ruddy KJ, Tamimi RM, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Wong JS, Partridge AH, Rosenberg SM. Dominici L, et al. Among authors: king ta. JAMA Surg. 2021 Oct 1;156(10):e213758. doi: 10.1001/jamasurg.2021.3758. Epub 2021 Oct 13. JAMA Surg. 2021. PMID: 34468718 Free PMC article.

2

Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures.

Chen CM, Cano SJ, Klassen AF, King T, McCarthy C, Cordeiro PG, Morrow M, Pusic AL. Chen CM, et al. Breast J. 2010 Nov-Dec;16(6):587-97. doi: 10.1111/j.1524-4741.2010.00983.x. Breast J. 2010. PMID: 21070435 Review.

3

Selecting local therapy in the young breast cancer patient.

King TA. King TA. J Surg Oncol. 2011 Mar 15;103(4):330-6. doi: 10.1002/jso.21697. J Surg Oncol. 2011. PMID: 21337567 Review.

4

Magnetic resonance imaging in patients with newly diagnosed breast cancer: a review of the literature.

Pilewskie M, King TA. Pilewskie M, et al. Among authors: king ta. Cancer. 2014 Jul 15;120(14):2080-9. doi: 10.1002/cncr.28700. Epub 2014 Apr 18. Cancer. 2014. PMID: 24752817 Free article. Review.

5

The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.

Oppong BA, Pharmer LA, Oskar S, Eaton A, Stempel M, Patil S, King TA. Oppong BA, et al. Among authors: king ta. Cancer Med. 2014 Aug;3(4):1025-34. doi: 10.1002/cam4.259. Epub 2014 Jun 18. Cancer Med. 2014. PMID: 24944108 Free PMC article.

6

Developing a service model that integrates palliative care throughout cancer care: the time is now.

Partridge AH, Seah DS, King T, Leighl NB, Hauke R, Wollins DS, Von Roenn JH. Partridge AH, et al. J Clin Oncol. 2014 Oct 10;32(29):3330-6. doi: 10.1200/JCO.2013.54.8149. Epub 2014 Sep 8. J Clin Oncol. 2014. PMID: 25199756

7

Timeliness in Breast Cancer Treatment-The Sooner, the Better.

Waks AG, King TA, Winer EP. Waks AG, et al. Among authors: king ta. JAMA Oncol. 2016 Mar;2(3):302-4. doi: 10.1001/jamaoncol.2015.4506. JAMA Oncol. 2016. PMID: 26658500 No abstract available.

8

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.

Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC. Denduluri N, et al. Among authors: king ta. J Clin Oncol. 2016 Jul 10;34(20):2416-27. doi: 10.1200/JCO.2016.67.0182. Epub 2016 Apr 18. J Clin Oncol. 2016. PMID: 27091714

9

Contralateral prophylactic mastectomy and quality of life: answering the unanswered questions?

Rosenberg SM, King TA. Rosenberg SM, et al. Among authors: king ta. Gland Surg. 2016 Jun;5(3):261-2. doi: 10.21037/gs.2016.04.05. Gland Surg. 2016. PMID: 27294031 Free PMC article. No abstract available.

10

Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.

Radosa JC, Eaton A, Stempel M, Khander A, Liedtke C, Solomayer EF, Karsten M, Pilewskie M, Morrow M, King TA. Radosa JC, et al. Among authors: king ta. Ann Surg Oncol. 2017 Mar;24(3):698-704. doi: 10.1245/s10434-016-5631-3. Epub 2016 Oct 25. Ann Surg Oncol. 2017. PMID: 27783163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page